Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Health
Amsterdam
gay men
GGD Amsterdam
HIV
HIV inhibitor
HIV prevention pill
Prep
Monday, 10 August 2015 - 15:01
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

HIV prevention pill in high demand in Amsterdam

The new HIV inhibitor Prep is in high demand among gay men living in the capital. GGD Amsterdam recently announced a trial on the pill that reduces the risk of HIV infection. Only 370 men can participate in the study, but the number of applications were much higher. A spokesperson for GGD Amsterdam said this to the Telegraaf on Monday. Prep is meant for people who do not have HIV, but are at an increased risk of becoming infected. The pill has little known side effects and is already freely available in the United States. The GGD trial will last three years. According to NU., critics argue that while the pill indeed reduces the risk of HIV infection, it encourages more licentious behavior and does not prevent other diseases.

Follow us:

Latest stories

  • European office to gather proof of war crimes in Ukraine will set up in The Hague
  • Schiphol security finds knife concealed as passenger’s belt buckle
  • "Worrisome" decrease in student housing supply as rents increase 10%
  • Trade union announces more civil servants' strikes, including in The Hague
  • Nine suspects arrested in Netherlands for 50 ATM bombings in Germany
  • Student orgs. want temporary, not permanent limit on international students

Top stories

  • European office to gather proof of war crimes in Ukraine will set up in The Hague
  • Nine suspects arrested in Netherlands for 50 ATM bombings in Germany
  • Amsterdam to ban some tour buses from city center from 2024
  • Police missed many signals in run-up to attorney, crime journalist's murders: report
  • Public transport strike: No trains running in Friesland, part of Groningen
  • Dutch mad cow disease case concerns variant that is less dangerous for humans

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content